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Original Research Paper
Sensorimotor function in progressive multiple
sclerosis
Jules D Miehm , John Buonaccorsi, Jongil Lim, Sumire Sato, Caitlin Rajala, Julianna Averill,
Farnaz Khalighinejad, Carolina Ionete, Stephanie L Jones, Jane A Kent and
Richard EA van Emmerik
Abstract
Background: A sensitive test reflecting subtle sensorimotor changes throughout disease progression
independent of mobility impairment is currently lacking in progressive multiple sclerosis.
Objectives: We examined non-ambulatory measures of upper and lower extremity sensorimotor function
that may reveal differences between relapsing–remitting and progressive forms of multiple sclerosis.
Methods: Cutaneous sensitivity, proprioception, central motor function and mobility were assessed in 32
relapsing–remitting and 31 progressive multiple sclerosis patients and 30 non-multiple sclerosis controls.
Results: Cutaneous sensation differed between relapsing–remitting and progressive multiple sclerosis at
the foot and to a lesser extent the hand. Proprioception function in the upper but not the lower extremity
differed between relapsing–remitting and progressive multiple sclerosis, but was different for both upper
and lower extremities between multiple sclerosis patients and non-multiple sclerosis controls. Foot-tap
but not hand-tap speed was slower in progressive compared to relapsing–remitting multiple sclerosis,
suggestive of greater central motor function impairment in the lower extremity in progressive multiple
sclerosis. In addition, the non-ambulatory sensorimotor measures were more sensitive in detecting
differences between relapsing–remitting and progressive multiple sclerosis than mobility assessed
with the 25-foot walk test.
Conclusion: This study provides novel information about changes in sensorimotor function in progressive
compared with relapsing–remitting forms of multiple sclerosis, and in particular the importance of assess-
ing both upper and lower extremity function. Importantly, our findings showed loss of proprioceptive
function in multiple sclerosis but also in progressive compared to relapsing–remitting multiple sclerosis.
Keywords: Relapsing–remitting multiple sclerosis, progressive multiple sclerosis, cutaneous sensation,
proprioception, tapping performance
Date received: 22 January 2020; accepted: 24 May 2020
Introduction
Progressive multiple sclerosis (PMS) is a subtype of
multiple sclerosis (MS) characterized by a steadily
worsening disease course, generally leading to pro-
found disability. While only a small proportion of
individuals are diagnosed with primary progressive
multiple sclerosis (PPMS) at disease onset, it is esti-
mated that as many as 90% of those with relapsing–
remitting multiple sclerosis (RRMS) will ultimately
transition to a secondary progressive form of multi-
ple sclerosis (SPMS).1 Despite the high prevalence
of transitions from relapsing to PMS, existing
treatments are ineffective in forestalling the decline
in body functions associated with PMS.2 Mobility is
a key construct included in many scales used to
assess function and disease progression in MS,
including the most widely used instrument, the
Expanded Disability Status Scale (EDSS),3–5 as
well as the 25-foot walk (25FWT)6 and timed up-
and-go test (TUG).4 While early changes in EDSS
and 25FWT are predictive of long-term disability,5 a
sensitive test reflecting subtle sensorimotor changes
throughout disease progression and independent of
mobility impairment is lacking, thus hampering
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early and appropriate treatment during the transition
to PMS.
There is a high prevalence of somatosensory impair-
ments in people with multiple sclerosis (PwMS)7–11
and strong associations between impaired somato-
sensation and balance.7,8 Plantar cutaneous sensation
appears to worsen with disease duration and in PMS,
independent of age-related changes.10,12 Despite the
recognition that proprioception is commonly affect-
ed in balance-impaired PwMS,13 relatively little is
known about the role of proprioception in disease
progression. Fling and colleagues13 found poorer
balance control on high-demand proprioceptive
tasks, as well as reduced white matter integrity of
the cortical proprioceptive tracts in PwMS, especial-
ly those related to lower extremity proprioceptive
pathways to Brodmann area 3a. Jamali and col-
leagues14 assessed a variety of sensorimotor function
tests in RRMS, and found that proprioceptive
impairments were more prominent in MS than cuta-
neous deficits. However, from this study it is not
known how proprioceptive function in PMS relates
to RRMS, although it has been suggested that pro-
prioception may be worse in PMS compared to
RRMS.10
Alterations in motor function, including muscle
weakness and spasticity, are commonly reported by
PwMS.12,15–19 Importantly, changes in motor func-
tion that reflect altered central motor function or
power asymmetry correlate with balance or mobility
impairment more so than strength.15,16,20 Dorsiflexor
muscle weakness is associated with poor foot-tap
performance in PwMS, and foot-tap speed is lower
in PwMS compared to non-MS controls.15,20,21 A
recent study22 found reduced foot and finger-
tapping performance in PMS compared to RRMS,
but observed no differences in foot or finger tapping
between people with RRMS and non-MS controls.
The goal of this study was to examine non-
ambulatory outcome measures of sensorimotor func-
tion that may be sensitive in finding differences
between RRMS and progressive forms of MS. We
addressed the following research questions: (a)
which lower- and upper-extremity measures of sen-
sorimotor function (cutaneous sensitivity; proprio-
ception; central motor function) differ between
PMS and RRMS cohorts and between the MS
cohorts and non-MS controls? and (b) how well do
the individual sensorimotor variables classify partic-
ipants into the RRMS and PMS subgroups? We
hypothesized that: (a) cutaneous sensitivity will
decrease from controls to RRMS to PMS;10,12 (b)
central motor function (reduced foot-tapping
ability) in MS groups overall will be impaired com-
pared to controls;15,20,21 and (c) foot and hand-




The study included three cohorts ranging in age from
24 to 80 years: RRMS (n¼32); PMS (n¼31), includ-
ing PPMS (n¼7) and SPMS (n¼24); and healthy,
non-MS controls (CON; n¼30). The controls were
chosen so the sex and age distribution was approxi-
mately like that of the combined MS subjects. We did
not attempt any age matching of the two MS sub-
groups, because the onset of the progressive phase
of the disease is age-dependent such that people
with PMS are inherently older.23 Group characteris-
tics are reported in Table 1. The MS participants were
recruited and tested at the UMass Memorial Medical
MS Center, while the non-MS control group was
tested at UMass Amherst. The PMS group consisted
of people who had been definitively diagnosed with
either PPMS or SPMS according to the McDonald
criteria.24 People with PPMS and SPMS were
grouped together as their clinical characteristics
such as EDSS levels were comparable (see
Supplementary file 1).25,26 People with clinically iso-
lated syndrome or probable MS were excluded. This
research was approved by the institutional review
boards at UMass Memorial Medical Center and
UMass Amherst, and written informed consent was
obtained from all participants.
Procedures
For both MS groups a clinical neurologist with train-
ing in neuroimmunology research at the MS Center
evaluated the following measures bilaterally: muscle
spasticity of the elbow flexors and ankle dorsiflexors
using the modified Ashworth scale;27 plantar reflex
following the Babinski method; disability status by
the EDSS;3 and MS diagnostic status (i.e. RRMS,
PPMS or SPMS) according to the McDonald crite-
ria24 (Table 1). The following sensorimotor and
functional measures were obtained.
Vibration perception threshold. A biothesiometer
(Bio-Medical Instruments Co., Newbury, OH,
USA) was used to measure cutaneous sensation of
both hands (thumb pad, index finger pad, ulnar side
of palm) and feet (hallux pad, fifth metatarsal, heel),
while blindfolded. Vibration amplitude was steadily
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increased until participants verbally confirmed they
felt vibration.28 The bilateral average over two trials
at three sites on both hands and feet was reported,
with a lower number (threshold) indicating greater
vibration sensitivity.
Proprioception. Custom-built manipulanda (elbow,
ankle) coupled with a data acquisition analog-to-
digital converter (USB-6000, National Instruments,
Austin, TX, USA) and custom-written MATLAB
program (The MathWorks, Inc., Natick, MA, USA)
were used to assess bilateral elbow and ankle pro-
prioception through contralateral joint position-
matching tests,29 while blindfolded (Figure 1). To
assess elbow proprioception,30,31 the control arm
was abducted at an angle of approximately 45 at
the shoulder and then passively set to 30 of elbow
flexion by the experimenter; participants then active-
ly moved the contralateral test limb until they sensed
that the elbow flexion between the two limbs was
matched. Similarly, ankle proprioception32 was
assessed by setting the control foot to 15 dorsiflex-
ion and asking participants actively to match the test
foot. For both elbow and ankle proprioception, the
average joint position () during the final 3 seconds
was used to obtain the absolute error (jDj) between
the set (control) limb and the matched (test) limb,
and the bilateral average over a maximum of three
trials is reported.
For the finger (whole arm)-matching task, the target
position was defined by the index finger of the con-
trol limb placed underneath a custom-assembled
solid surface (acrylic sheet) in the center of the
grid. Participants were instructed to position the
index finger of the contralateral test limb directly
on top of the acrylic sheet where they sensed it
was directly on top of the control limb finger posi-
tion. The mean radial distance (cm) of each repeti-
tion was calculated, and the bilateral average over a
maximum of three trials is reported.
Tapping ability. Two wearable inertial sensors (The
Opal, Version 2; APDM Wearable Technologies,
Portland, OR, USA) were used to evaluate perfor-
mance during rapid hand and foot tapping.
Participants received instructions to tap as fast as
possible for 10 seconds based on established proce-
dures.15,22 Tap count was derived from ascending
zero crossings of angular velocity, and the average













Age (years) 55.1 12.3 52.3 9.9 60.0 8.3 0.006 0.002 –12.3, –3.1
Female (%) 80.0 90.6 64.5 0.048 0.016 –
Height (cm) 166.8 7.7 160.4 6.2 170.4 11.0 <0.001 <0.001 –14.5, –5.4
Body mass (kg) 69.9 10.0 80.1 16.3 88.1 25.6 <0.001 0.146 –18.9, 2.9
BMI (kgm–2) 25.2 4.1 31.2 6.7 30.2 7.8 <0.001 0.559 –2.6, 4.7
Disease duration (years) NR 12.4 8.6 22.1 12.1 NR <0.001 –15.1, –4.3
EDSS NR 3.2 2.2 5.9 1.7 NR <0.001 –3.6, –1.7
Ashworth right biceps brachii NR 0.09 0.4 0.3 0.7 NR 0.193 –0.5, 0.1
Ashworth left biceps brachii NR 0.03 0.2 0.1 0.5 NR 0.213 –0.3, 0.1
Ashworth right TA NR 0.3 0.7 0.9 1.1 NR 0.015 –1.1, –0.1
Ashworth left TA NR 0.1 0.3 0.6 1.1 – 0.014 –1.0, –0.1
Babinski Right Foot NR 3 present 12 present – <0.01 –
Babinski Left Foot NR 3 present 10 present – 0.03 –
25FWT preferred speed (s) 7.0 1.0 10.7 5.3 14.5 11.1 <0.001 0.169 –9.3, 1.7
25FWT maximal safe speed (s) 4.9 0.5 8.5 4.8 11.8 8.7 <0.001 0.121 –7.7, 0.9
TUG (s) 6.6 1.0 12.4 7.7 18.1 14.0 <0.001 0.109 –12.8, 1.4
Ambulatory (%) 100.0 96.9 77.4 0.003 0.027 –
9HPT (s) 19.7 2.6 31.8 19.6 37.5 26.2 0.002 0.445 –20.9, 9.4
Data are mean standard deviation.
RRMS: relapsing–remitting multiple sclerosis; PMS: progressive multiple sclerosis; BMI: body mass index; EDSS: Expanded Disability Status
Scale; TA: tibialis anterior; 25FWT: 25-foot walk time; TUG: timed up-and-go; 9HPT: 9-hole peg test; NR: not reported.
TUG is the average of two trials; 9HPT is the bilateral average of two trials.
Miehm et al.
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10-second tap count over three bilateral trials was
recorded.
Mobility and upper extremity function. Mobility
function was assessed with the 25FWT (preferred
and maximal safe speed) and average TUG test
(two trials).33 Nine RRMS and 12 PMS participants
used walking aids during the mobility tests, ranging
from ankle-foot orthotics to rollators. Upper limb
function was assessed bilaterally twice using the
nine-hole peg test (9HPT).6,34
Statistical analysis
The primary dependent variables were upper and
lower-extremity measures of sensorimotor function
including vibration perception threshold (VPT), pro-
prioception and tapping ability. Secondary dependent
variables included clinical, mobility and upper extrem-
ity function measures (Table 1). For each continuous
outcome, the three groups were compared using anal-
ysis of variance (ANOVA), allowing unequal varian-
ces (Welch’s test). This was complemented by 95%
confidence intervals and t-tests for differences in
group means, again allowing for unequal variances
(Satterthwaite’s method). Categorical clinical meas-
ures were compared between RRMS and PMS using
Fisher’s exact test. As the ability to classify
individuals into groups is a function of both group
means and their variability, logistic regression35 was
used to explore the ability of the individual measures,
and combinations of them, to assign an MS participant
into the RRMS or PMS group. In our main analysis
we did not explore the effects of possible confounding
variables, such as disease duration or age, which by
nature of MS differ between MS subtypes.1 Unlike
randomized control trials in which a potential con-
founder gets unbalanced due to the randomization,
this was an observational study and correcting for a
variable, which by nature differs between groups, will
change the research question.36 However, we did per-
form additional analyses comparing the non-MS con-
trol group and each MS subgroup, matched for age
(see Supplementary file 2 data). Statistical signifi-
cance was established at an alpha level of less than
0.05. All statistical analyses were performed using
SAS 9.4 (SAS Institute, Cary, NC, USA).
Results
Group and functional measures
There was a main effect of group for age, height,
body mass and body mass index (BMI) (Table 1).
Pairwise comparisons that assumed unequal
Figure 1. Set-up of proprioceptive matching tasks. (a)–(c) Schematics of upper (a) and (b) and lower-extremity pro-
prioception (c) during a joint position-matching task at the elbow (a) and ankle (c) and a whole upper-limb-matching task
using a target grid and matching with the index finger (b). For elbow-matching (a), the set elbow was positioned to 30 in
the transverse plane. For ankle-matching (c), the set foot was positioned to 15 dorsiflexion. For whole-limb-matching
(b), the set index finger was positioned underneath the grid (10 10 cm) to x, y coordinates [0, 0].
Multiple Sclerosis Journal — Experimental, Translational and Clinical
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variances indicated that RRMS and PMS had similar
body mass and BMI, but that PMS was older and
taller (Table 1). There was a longer disease duration
in PMS than RRMS (P<0.001, 95% CI –15.1, –4.3),
and a main effect for EDSS (P<0.0001, 95% CI
–3.6, –1.7), indicating a greater degree of disability
in PMS compared to RRMS. There was a main
effect of group for all mobility tests and the 9HPT,
but no difference between RRMS and PMS in these
measures.
Sensorimotor function
Foot VPT. Group differences were observed for
VPT at the fifth metatarsal (F2,87¼21.15,
P<0.0001); post hoc pairwise comparisons showed
that the ability to sense vibration declined from CON
to RRMS to PMS groups (Table 2; Figure 2).
The same results were obtained for sensitivity at
the hallux and heel.
Hand VPT. VPT showed group effects for all three
sites: index finger (F2,88¼6.99, P¼<0.001), thumb
(F2,88¼9.81, P<0.001) and palm (F2,88¼5.16,
P<0.001). Pairwise comparisons indicated differen-
ces between controls and both MS groups, with CON
showing lower thresholds (Table 3; Figure 3).
Differences between RRMS and PMS were observed
for the thumb and a trend for differences at the index
finger, with PMS showing a higher threshold than
RRMS. No difference was observed between RRMS
and PMS for the palm.
Table 2. Lower-extremity sensorimotor variables.
Variable Controls RRMS PMS P value
Hallux VPT (V) 10.60 5.44 15.23 12.10 26.38 13.52 <0.001
Fifth Met VPT (V) 8.39 4.93 13.62 12.72 28.46 16.42 <0.001
Heel VPT (V) 9.68 6.56 15.19 11.97 28.50 15.07 <0.001
Ankle matching (jDj) 2.29 0.66 4.26 2.82 4.70 2.17 <0.001
Foot-tap count (10 s) 45.95 4.29 37.43 9.57 29.63 7.67 <0.001
Data are mean  standard deviation.
RRMS: relapsing–remitting multiple sclerosis; PMS: progressive multiple sclerosis; VPT: vibration perception
threshold; V: volts; Met: metatarsal; jDj: absolute difference in degrees between the set and matched limb; s: seconds.
Measurements for each variable represent the bilateral average of two trials (VPT) and three trials (matching and
tapping).
P values for main effect of group are from one-way analyses of variance (ANOVAs). See Figure 2 for post hoc
pairwise comparisons.
Figure 2. Analysis of differences in group means for the lower extremity sensorimotor variables. RRMS: relapsing–
remitting multiple sclerosis; PMS: progressive multiple sclerosis; CON: non-multiple sclerosis control group; VPT:
vibration perception threshold; Met: metatarsal. Lines that do not cross zero indicate a difference between groups.
Miehm et al.
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Ankle proprioception. A group effect was observed
for the absolute error during ankle-matching
(F2,84¼10.98, P<0.001). Pairwise comparisons
revealed differences between CON and both
RRMS and PMS, but not between the two MS
groups (Table 2; Figure 2).
Finger and elbow proprioception. A group effect
was observed for the finger-matching error
(F2,89¼6.08, P¼0.002). Pairwise comparisons indi-
cated differences between PMS versus CON and
PMS versus RRMS, but not between CON versus
RRMS (Table 3; Figure 3). A group effect was
also observed for the elbow-matching error
(F2,86¼11.90, P<0.001), which was greater in
PMS compared to CON and RRMS. The difference
between RRMS and CON was modest and not
significant.
Foot tapping. A group effect was observed for
foot-tap count (F2,79¼32.04, P<0.001). Pairwise
comparisons showed the number of foot taps was
systematically lower from CON to RRMS to PMS
(Table 2; Figure 2).
Hand tapping. A group effect also was observed for
hand-tap count (F2,83¼14.30, P<0.001). Pairwise
comparisons showed the number of hand taps to be
lower in both MS groups compared to CON.
Table 3. Upper-extremity sensorimotor variables.
Variable Controls RRMS PMS P value
Thumb VPT (V) 3.06 0.94 4.78 2.67 7.33 5.88 <0.001
Index VPT (V) 3.17 0.94 4.93 3.31 7.83 7.76 <0.001
Palm VPT (V) 2.88 0.79 5.52 5.36 7.54 8.12 <0.001
Elbow-matching error (jDj) 4.81 2.08 5.68 2.33 8.58 4.40 <0.001
Finger-matching error (cm) 2.33 0.67 2.62 1.59 3.53 1.67 0.002
Hand-tap count (10 s) 62.80 5.98 53.03 10.70 50.80 9.50 <0.001
Data are mean  standard deviation.
RRMS: relapsing–remitting multiple sclerosis; PMS: progressive multiple sclerosis; VPT: vibration perception
threshold; V: volts; jDj: absolute difference in degrees between the set and matched limb; cm: centimeters; s: seconds.
Measurements for each variable represent the bilateral average of two trials (VPT) and three trials (matching and
tapping).
P values for main effect of group are from one-way analyses of variance (ANOVAs). See Figure 3 for post hoc
pairwise comparisons.
Figure 3. Analysis of differences in group means for the upper extremity sensorimotor variables. RRMS: relapsing–
remitting multiple sclerosis; PMS: progressive multiple sclerosis; CON: non-multiple sclerosis control group; VPT:
vibration perception threshold; Met: metatarsal. Lines that do not cross zero indicate a difference between groups.
Multiple Sclerosis Journal — Experimental, Translational and Clinical
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No difference in hand-tap count was observed
between RRMS and PMS (Table 3; Figure 3).
We also controlled for age in comparing non-MS
controls to RRMS and PMS groups. Matching the
non-MS controls to the PMS group resulted in the
same outcomes for all sensorimotor and mobility var-
iables presented above. The same result was obtained
in matching the non-MS control group to the RRMS
group (see Supplementary file 2 for full data).
Classification of participants into MS subgroups:
logistic regression
Single variable logistic regression suggested that the
most promising individual variables for distinguishing
the two MS groups were the average absolute error in
the elbow position-matching task, and the cutaneous
measures at the hallux, fifth metatarsal and age (clas-
sification rate; Table 4). We also considered logistic
models combining each of the variables with age
(incorporating an interaction term if needed). For
some variables the results with age led to substantial
increases in the estimated correct classification rate;
for the thumb VPT (from 60.7% to 70.4%), 25FWT
preferred (54% to 69.4%), ankle-matching error
(45.6% to 66.7%) and hand-tap count (44.8% to
64.3%) with all but the model with the thumb involv-
ing an interaction term. These age-adjusted improve-
ments did not surpass the best three variables
unadjusted for age (Table 4).
For multiple logistic regression, there were too many
variables relative to the number of observations to
use standard model-building methods on all varia-
bles. For pairs of variables, the best combinations
(where the model allowed for an interaction effect
through the product of the 2 variables) included the
average error at the elbow, with an estimated correct
classification rate of 78.9% when combined with the
sensitivity in any of hallux, fifth metatarsal or heel,
and 75.4% with the palm and index finger. Stepwise
selection resulted in the optimal model including
VPT at the fifth metatarsal, the elbow-matching
error and their interaction. These potential gains
are rather modest with respect to what was achieved
using a single variable at a time (Table 4).
Table 4. Single variable logistic regression analyses.
Variable b SEb P value
Classification
rate Low Up
Hallux VPT (V) 1.490 0.454 0.001 71.7 60.3 83.1
Fifth Met VPT (V) 1.397 0.395 <0.001 75.0 64.0 86.0
Heel VPT (V) 1.478 0.441 0.001 65.0 52.9 77.1
Index VPT (V) 1.390 0.574 0.015 65.6 53.7 77.5
Thumb VPT (V) 1.341 0.592 0.023 60.7 48.4 72.9
Palm VPT (V) 0.788 0.473 0.095 65.6 53.7 77.5
Finger-matching error (cm) 0.363 0.176 0.039 66.7 55.0 78.3
TUG (s) 0.064 0.041 0.115 59.2 45.4 72.9
25FWT preferred (s) 0.064 0.050 0.199 54.0 40.2 67.8
25FWT brisk (s) 0.087 0.060 0.145 60.0 46.4 73.6
Ankle-matching error (jDj) 0.070 0.107 0.512 45.6 32.7 58.5
Elbow-matching error (jDj) 0.291 0.107 0.006 72.9 61.5 84.2
Foot-tap count (10 s) –0.108 0.039 0.005 61.1 48.1 74.1
Hand-tap count (10 s) –0.023 0.027 0.396 44.8 32.0 57.6
9HPT (s) 0.016 0.017 0.330 53.8 38.2 69.5
Age 0.09 0.03 <0.001 68.3 56.8 79.7
Univariate logistic regression results for modeling and classifying MS group status (PMS vs. RRMS).
Based on a combination of diagnostics and goodness-of-fit tests, the cutaneous measures are log transformed for use in
the logistic model.
b: estimate of b; SEb: standard error for b; P: P value for testing H0: b ¼ 0; Classification Rate: estimated correct
classification rate using a 0.5 cut point and cross-validation; Low, Up: approximated 95% confidence interval for the
classification rate; RRMS: relapsing–remitting multiple sclerosis; PMS: progressive multiple sclerosis; VPT: vibration
perception threshold; V: volts; Met: metatarsal; TUG: timed up-and-go test; 25FWT: 25-foot walk test; jDj: absolute




Overall, these results demonstrate differences in sen-
sorimotor function between non-MS controls and
PwMS and, most importantly, between PMS and
RRMS cohorts, that are independent of ambulation.
First, vibration sensation was lower in both MS
groups, more so in the progressive group. This
reduction in vibration sensitivity was observed at
most of the sites tested on both hands and feet.
Second, proprioceptive function during the ankle-
matching task was lower in both MS groups com-
pared to controls, but no differences existed between
MS groups. In contrast, performance during elbow
and finger-matching differed between PMS and
RRMS. The logistic regression analysis also identi-
fied elbow proprioceptive function as a potential sig-
nificant classifier of MS subtype. This novel set of
results indicates that proprioceptive function may
not be impacted similarly across the body among
different MS subtypes. Third, central motor func-
tion, as assessed by tapping ability, was systemati-
cally reduced from controls to RRMS to PMS for
foot but not hand tapping, although both MS groups
showed lower hand-tapping ability compared to con-
trols. Our analyses suggest that both upper and
lower-extremity sensorimotor variables are impor-
tant in assessing differences between RRMS and
PMS subtypes.
In agreement with previous studies12,14,15 we found
differences in cutaneous sensation between RRMS
and controls for sites on the hands and feet. A novel
finding in this study was that we detected differences
in cutaneous sensation between RRMS and PMS at
all sites on the foot and, to a lesser extent, on the
hand. The more pronounced differences between
RRMS and PMS for locations on the foot suggest
that, although MS is a central nervous system dis-
ease, longer axons that serve mechanoreceptors on
the foot could be more susceptible to changes over
time or due to differences in disease processes in
PMS compared to RRMS. These findings highlight
the importance of testing cutaneous sensitivity
changes at the feet in MS, especially given its rele-
vance to balance control.11,13,15,21 The potential for
these measures to provide insight into the transition
from RRMS to SPMS is worth further exploration.
Fling et al.13 found that balance control in PwMS is
especially affected in tasks that put higher demands
on proprioceptive function; however, they did not
assess the relative loss of proprioceptive function
within upper and lower extremities. Jamali and col-
leagues14 assessed a variety of sensorimotor function
tests in RRMS, and found that proprioceptive
impairments were more prominent in MS than cuta-
neous (e.g. tactile pressure and vibration). Our
results indicate that evaluation of both upper and
lower-extremity proprioceptive function is important
when comparing RRMS and PMS subtypes. For the
lower extremity, both MS groups showed impaired
ankle proprioceptive function compared to non-MS
controls, with no differences between MS subtypes.
In contrast, for the upper limb both elbow and
whole-limb proprioceptive function was lower in
PMS than RRMS, with no differences between
RRMS and non-MS controls. This is in contrast to
Jamali and colleagues,14 who found a greater degree
of proprioceptive impairment in the lower compared
to the upper extremities. These different findings
could be the result of the sensitivity of the assess-
ment; Jamali et al.14 used global assessment of
movement and direction in response to passive
movement induced by the experimenter and ours
was active repositioning focused on precise match-
ing of the contralateral limb. Our findings regarding
the PMS group are novel and support the earlier
suggestion by Soyuer and colleagues10 that proprio-
ception may be worse in PMS compared to RRMS.
Overall, our results suggest that loss of propriocep-
tive function due to MS disease progression or dura-
tion may happen earlier in the upper compared to the
lower extremity, but this hypothesis requires further
testing.
In contrast to the results on proprioception, the MS
groups differed in lower but not upper-extremity tap-
ping function. A recent study reported similar foot-
tap counts between controls and RRMS.22 We found
that RRMS had lower foot-tapping ability compared
to controls. This discrepancy might be due to a
greater level of disability or dorsiflexor weakness
in our RRMS group compared with that of the pre-
vious study. In agreement with Tanigawa et al.,22 we
found that PMS had lower foot-tapping ability com-
pared to both controls and RRMS, probably due to
more significant spinal cord involvement in PMS.
As with foot tapping, we found that the ability to
tap the hand rapidly was lower in both MS groups
compared to controls. Unlike with foot tapping and
contrary to Tanigawa et al., hand-tapping ability did
not differ between the two MS groups in the current
study. Differences in scoring method for tapping
might explain this discrepancy; rather than assign a
score of zero for those who were physically unable
to perform the tapping task, as done previously,22 we
treated each case as a missing value. Assigning a
score of zero for someone who cannot perform a
Multiple Sclerosis Journal — Experimental, Translational and Clinical
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task would probably artificially lower the scores in
the PMS group.
To complement the group comparisons, the logistic
regression analysis revealed that the most promising
variables for distinguishing the two MS groups
reflected elbow proprioceptive function and the
lower-extremity vibration sensitivity measures on
the plantar surface of the foot. Adjusting for age in
the logistic regression analysis also raised the clas-
sification rate for the upper extremity cutaneous sen-
sitivity (thumb) and lower extremity ankle
proprioception. Overall classification rates of cuta-
neous and proprioceptive measures were higher than
those for mobility and tapping. These findings would
need to be confirmed in a larger study sample.
Although early changes in EDSS and 25FWT are
predictive of long-term disability,5 these measures
are highly dependent on mobility function. The sen-
sorimotor measures in the current study may lead
to a more comprehensive assessment of relapsing–
remitting and progressive forms of MS. The
finger-matching protocol, assessing upper limb pro-
prioceptive ability, in particular, could easily be
incorporated in a standard array of clinical tests.
Although the main focus of this study was on non-
ambulatory measures of sensorimotor function, we
assessed mobility function with the 25FWT and
TUG for those who were able to walk. For both
tests, the differences between controls and MS
groups were greater than those observed between
RRMS and PMS. This finding adds to the argument
above that that subtle physiological differences
between RRMS and PMS may be more detectable
in the non-ambulatory, sensorimotor measures pre-
sented here compared to standard clinical tests of
25FWT and TUG. Although further investigation is
needed to determine whether we can build a battery
of tests based on sensorimotor function measures
that classify people into either RRMS or PMS
cohorts, our preliminary findings on the ability of
the sensorimotor measures to detect differences
between MS groups are promising.
In summary, this study provides novel information
about changes in sensorimotor function in progres-
sive compared with relapsing–remitting forms of
MS. Our results show the importance of assessing
both upper and lower-extremity sensorimotor
changes in comparing PMS and RRMS subtypes.
Importantly, our findings provided novel informa-
tion regarding loss of proprioceptive function in
MS and between the MS subtypes; loss of
proprioceptive function due to MS disease progres-
sion or duration may happen earlier in the upper
compared to the lower extremity. Our findings also
suggest that proprioceptive and motor pathways may
be affected differently for the upper and lower
extremities between people with relapsing–remitting
and progressive subtypes of MS. Future studies
should focus on the potential to exploit these differ-
ences in order to detect early and subtle changes
associated with a transition to secondary progressive
MS prior to overt mobility impairment.
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